Background: Human Immunodefi ciency Virus (HIV) infected patient frequently report upper gastrointestinal (GI) symptoms; however their prevalence and diagnostic approach is not well known. Objective: The objective of this study was to study clinical, endoscopic and histopathological changes in HIV infected patients with upper GI symptoms and their correlation with CD4 count. Materials and methods: We evaluated 50 HIV infected patients who presented to M.S. Ramaiah hospital with upper GI symptoms. All patients answered questionnaire assessing upper GI symptoms and underwent upper GI endoscopy. Mucosal biopsy was taken wherever mucosal abnormality seen. Results: In our study, the mean age of patients was 40.98 yrs, of which 80% were males. Vomiting (36%), epigastric pain (36 %), weight loss (34 %) and anorexia (34%) were the predominant symptoms. Esophagogastroduodenoscopy (EGD) fi ndings revealed-Oesophageal candidiasis in 28.0%, esophagitis in 22.0%, gastritis in 20.0 %, duodenitis in 14 %, normal upper GI mucosa in 18 % patients. Oesophageal candidiasis was the most common fi nding on histopathological examination and the mean CD4 count was 157.92 cells/μl. Conclusion: Vomiting, epigastric pain, weight loss and anorexia were most frequent symptoms. Oral candidiasis was the most common oral lesion. Oesophageal candidiasis, oesophagitis and oesophageal ulcers were the common fi ndings on EGD. Patient with CD4 count less than 200cells/μl had more frequent upper GI mucosal involvement than in patients with CD4 count more than 200. Majority of the patients with GI symptoms had upper GI mucosal changes and opportunistic infections. Thus endoscopic and histopathological evaluation is advisable for the early diagnosis and treatment of upper GI complications in patients with HIV infection.
T he spectrum of the HIV infection varies from asymptomatic infection to acquired immunodefi ciency syndrome (AIDS). The GI tract has long been recognised as a major site of HIV related diseases and up to 90% of HIV infected patients experience GI symptoms during the course of their disease. However, the exact prevalence and diagnostic approach in these patients is not clearly defi ned 1 . HIV infection leads to progressive deterioration of both the general and the local immune defence system of the GI tract mucosa 2, 3 . Opportunistic infections are the most frequent GI complications of HIV infection and remain a major cause of morbidity and mortality in these patients 2, 4 . These diseases account for high prevalence of upper GI symptoms such as dysphagia, odynophagia, abdominal pain 5, 6 . With the progression of immunodefi ciency, EGD becomes a useful diagnostic modality for the early diagnosis of these opportunistic infections and other infl ammatory conditions 7, 8 . Hence we studied the clinical, endoscopic and biopsy changes in HIV patients with upper GI symptoms.
Materials and methods
This prospective observational study was undertaken in 50 HIV infected patients with upper GI symptoms presenting to M.S.Ramaiah hospital to evaluate clinical, endoscopic and histopathologic changes in HIV infected patients with upper gastro intestinal symptoms and to correlate with CD 4 count. All HIV infected patients above 18 yrs presenting with upper GI symptoms from november 2007 to october 2009 were included. HIV patients with other associated immunocompromised states, chronic liver disease, chronic renal failure, steroid therapy, chronic NSAIDs and antifungal therapy were excluded as they may be confounding factors for upper GI symptoms. All patients answered a questionnaire and were subjected to physical examination followed by investigations (complete blood count, renal function tests, liver function tests, Urine routine, Chest x ray, ELISA for HIV 1 and 2, Western Blot and CD4 count). Swabs were collected in cases presenting with oral / oropharyngeal thrush.
All patients were subjected for upper GI endoscopy after taking prior consent. Premedication was given with Xylocaine mouth wash and Midazolam 2mg intravenous injection. Pentax EG 290 P video endoscope was used to visualise the upper GI tract. It was disinfected with 2 % glutaraldehyde before and after the procedure. Oesophageal, gastric and duodenal mucosa was carefully examined for evidence of infl ammation, ulceration, erosions, oedema, hemorrhagic patches and opportunistic infection. Mucosal biopsy, followed by histopathological examination was done if mucosal abnormality was found. Biopsy specimens were immediately fi xed in buffered formalin and submitted for histopathologic study. Routine histological evaluation (haematoxylin and eosin; H&E), immunohistochemistry staining for CMV and HSV antigens and staining for mycobacterium, fungi (Gomori-methenamine-silver nitrate and periodic acid-Schiff) and microsporidia (Gram and or trichrome stain) were performed where appropriate. Biopsy specimens for light microscopy were processed using standard techniques.
Results
We studied 50 HIV infected patients with upper GI symptoms. The mean age in years was 40.98. Majority were males, who constituted 80 % and females 20 %. Thirty six(72.0%) patients were not on anti retroviral therapy. The major presenting symptoms were vomiting and epigastric pain, which constituted 36.0 % each, followed by dysphagia in 26.0 %, nausea in 22 % (Table  1 The major presenting symptoms were vomiting, epigastric pain and dysphagia. Candidiasis, esophagitis and gastritis were the common fi ndings on esophago-gastro-duodenoscopy.
Discussion
Gastrointestinal manifestations are among the most frequent complaints in patients with HIV infection. The reported incidence of GI manifestation in the literature varied from 50% to 93% 5, 9 . Majority of the patients presented with vomiting, epigastric pain and dyspepsia. Oral candidiasis, oesophageal candidiasis and oesophagitis were most commonly seen lesions. 14 out of 50 patients were on ART and all of them were on Zidovudine, Lamivudine and Nevirapine. Among patients receiving ART, 7 had oesophagitis, 4 had oesophageal ulcer and one had normal upper GI mucosa. ART drugs are known to cause oesophageal ulceration. Therefore, patients should be advised to take medication after food and in upright position to decrease the irritant effect. Symptoms and signs alone rarely suggest a specifi c aetiology or severity. Much of the frustration of managing GI disease results from confusing diagnostic process. Usage of symptom frequency and severity of symptoms correlate poorly with abnormalities on EGD. Study conducted by Corley D.A, Cello J.P, Koch J, evaluated the clinical predictors of abnormal endoscopic fi ndings and utility of EGD for diagnosis in patients infected with HIV. They concluded that neither there were any independent symptoms predicting treatable disease on EGD nor there was any signifi cance between severity of symptoms and EGD changes 5 .
The evaluation of specifi c gastrointestinal complaints must be based on an assessment of the degree of immunosuppression. Progressive immunocompromised state is associated with increasing prevalence of GI symptoms 10 . Endoscopic evaluation of the GI tract remains a cornerstone of diagnosis, especially in patients with advanced immunodefi ciency, who are at risk for opportunistic infection. The CD4 lymphocyte count helps to predict the risk of an OI, with the highest risk seen in HIV-infected patients with low CD4 count (< 200 cells/ μl) 11 . Demonstration of a pathogen in tissue is the most specifi c means of establishing an etiologic diagnosis in opportunistic infections 6 .
In our study, 70 % patients were having CD4 count less than 200cells/ μl, indicating patients with CD4 count less than 200cells/ μl had more frequent upper GI mucosal involvement and opportunistic infection when compared to those with CD4 count more than 200cells/ μl. In a study done by Olmos MA et al, upper GI endoscopy with biopsies more frequently detected opportunistic and non-opportunistic diseases in HIV infected patients with upper gastrointestinal symptoms. Opportunistic diseases were related to lower CD4 counts. Non-opportunistic diseases had similar frequency in both groups, HIV positive and negative controls 12 . Pathogens are not usual in normal oesophagoduodenal mucosa of HIV infected patients with dyspepsia. In oesophagus and duodenum, biopsies should only be taken in advanced immunocompromised patients 13 .
EGD in HIV patients can serve the following purposes: 1) Many diseases which cannot be diagnosed by routine investigations and require specifi c treatment can be diagnosed by EGD. 2) Prescribing empirical treatment without performing upper endoscopy might put the patients at risk of many side effects from the unnecessary medicines, for instance H2 blocker for abdominal pain may predispose the patient to fungal overgrowth, and 
Conclusion
Upper-GI endoscopy identifi ed a diverse spectrum of disease and provided information that would be clinically relevant to most HIV-infected patients with upper GI symptoms. Majority of the patients with GI symptoms had upper GI mucosal changes and opportunistic infections, thus endoscopic and histopathological evaluation is advisable for the early diagnosis and treatment of upper GI complications in patients with HIV infection.
In the light of low CD4 count strongly correlating with upper GI symptoms and endoscopic fi ndings of opportunistic infections in the present study, routine EGD in asymptomatic HIV infected patients with CD4 count < 200cells/ μl may be useful, after validation by a larger study.
